QXO framed as a disciplined M&A compounder
The bull case argued for QXO hinges on Brad Jacobs' capital allocation track record to scale revenues to $50B via opportunistic roll-ups and aggressive post-synergy margin expansion.
Sign in to read the full idea
The argument, what validates it, the risks discussed and hearing it from the source are for signed-in members. Free accounts read 3 ideas in full a day — no card required.